Our Insights
Our insights
As access experts, we keep our finger on the pulse of a fast-moving environment. We have created this space as a touchstone through which you can keep up to date with the latest expanded access activity and insights.
Navigating the new era – Launch success in Europe’s evolving pharma landscape
Turning the heterogeneity of Europe into commercial success
Equitable access: How can we make advanced therapies a reality or possibility for all mankind?
The role of expanded access in advanced therapies
Cross-border Expanded Access Programs: Reducing barriers to treatment access
Three key steps to bring EAPs to a global market
Evaluating the cost impact of an Expanded Access Program
Implementing real-world data collection in Expanded Access Programs (EAPs)
The real value of mapping the Expanded Access Program (EAP) ecosystem
Optimizing commercial launch for orphan drugs with Expanded Access Programs
New partnership announcement
